FOLH1 and prostate carcinoma: A group of researchers in the Netherlands is looking to investigate if androgen deprivation therapy can increase the uptake of 68Ga-PSMA in patients with salivary duct cancers (SDCs), as has previously been demonstrated in prostate cancer (NCT04214353).